Drug recall D-0468-2024
Product
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13
Reason for recall
Cross Contamination with Other Products
Lots and codes
Lot # AMS00223A, Exp 07/31/2025
Recall details
- Recalling firm
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd., Tokushima, N/A
- Quantity
- N/A
- Distribution
- USA nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- April 9, 2024
Related products
- Abilify – drug information
- NDC 59148-006 Abilify · Aripiprazole 2 mg/1 · Otsuka America Pharmaceutical, Inc.
- NDC 59148-008 Abilify · Aripiprazole 10 mg/1 · Otsuka America Pharmaceutical, Inc.
- NDC 59148-010 Abilify · Aripiprazole 20 mg/1 · Otsuka America Pharmaceutical, Inc.
- NDC 59148-009 Abilify · Aripiprazole 15 mg/1 · Otsuka America Pharmaceutical, Inc.
- NDC 59148-007 Abilify · Aripiprazole 5 mg/1 · Otsuka America Pharmaceutical, Inc.
- NDC 59148-011 Abilify · Aripiprazole 30 mg/1 · Otsuka America Pharmaceutical, Inc.